[The latest diagnosis and treatment on deep-seated mycosis. Expectations for micafungin, the first candin in Japan (discussion)].
Shigeru
S
Kohno
Yoshito
Y
Niki
Yoshio
Y
Takematsu
Minoru
M
Yoshida
D000935:Antifungal Agents / Q000494:pharmacology / Q000627:therapeutic use*; D003937:Diagnosis, Differential; D025141:Drug Resistance, Fungal; D004359:Drug Therapy, Combination; D054714:Echinocandins; D005658:Fungi / Q000187:drug effects; D006801:Humans; D016867:Immunocompromised Host; D055666:Lipopeptides; D008074:Lipoproteins / Q000494:pharmacology / Q000627:therapeutic use*; D000077551:Micafungin; D009181:Mycoses / Q000175:diagnosis* / Q000188:drug therapy* / Q000453:epidemiology / Q000382:microbiology; D010456:Peptides, Cyclic / Q000494:pharmacology / Q000627:therapeutic use*
D000935:Antifungal Agents; D054714:Echinocandins; D055666:Lipopeptides; D008074:Lipoproteins; D010456:Peptides, Cyclic; D000077551:Micafungin